International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury

Ann Oncol. 1999 Jan;10(1):13-9. doi: 10.1023/a:1008397220178.

Authors

M A Shipp¹, M D Abeloff, K H Antman, G Carroll, A Hagenbeek, M Loeffler, E Montserrat, J A Radford, G Salles, N Schmitz, M Symann, J O Armitage, B Coiffier, T Philip

Affiliation

¹ Dana-Farber Cancer Institute, Boston, MA, USA. [email protected]

PMID: 10076716
DOI: 10.1023/a:1008397220178

No abstract available

Publication types

Consensus Development Conference
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Clinical Trials as Topic
Combined Modality Therapy
Dose-Response Relationship, Drug
Female
Hematopoietic Stem Cell Transplantation / standards*
Humans
Lymphoma, Non-Hodgkin / mortality
Lymphoma, Non-Hodgkin / physiopathology
Lymphoma, Non-Hodgkin / therapy*
Male
Prognosis
Severity of Illness Index
Survival Rate
Treatment Outcome